What Is a Clinical Evaluation Report (CER)?

A Clinical Evaluation Report is a scientific document that evaluates all clinical data related to a medical device. The purpose of a CER is to prove that the device is safe, performs as intended and provides clinical benefits to patients. It is not only a regulatory requirement but also a continuous process that must be updated throughout the device’s lifecycle.

CERs are required for medical devices of all classes, from low-risk products to high-risk implants. Under EU MDR, the expectations for CERs have become stricter, requiring stronger evidence, thorough analysis and updated literature reviews.

The CER forms a major part of the Technical File or Design Dossier that manufacturers submit to Notified Bodies for CE marking.

Why CERs Are Important for Medical Device Manufacturers

Clinical Evaluation Reports play a central role in device approval, surveillance and market access. Their importance can be understood through the following key points.

First, regulators worldwide, especially the EU, expect manufacturers to demonstrate clinical evidence for their devices. Without a CER, the device cannot be marketed or certified.

Second, a CER provides the scientific justification for safety and performance. It shows regulators that the device meets essential requirements, such as chemical safety, biological safety, mechanical performance and user safety.

Third, CERs support post-market surveillance. Even after market approval, manufacturers must keep updating the CER with new clinical data, complaint trends, vigilance findings and literature updates. This helps maintain regulatory compliance throughout the product lifecycle.

Finally, CERs protect patient safety by ensuring that clinical risks are properly identified, assessed and mitigated.

Regulatory Framework for Clinical Evaluation

The clinical evaluation process is guided by the MEDDEV 2.7/1 Rev. 4 guidelines and reinforced by EU MDR requirements. These documents outline the expectations, structure and depth of analysis needed in a CER.

EU MDR requires stronger clinical evidence compared to previous regulations. This includes:

• Detailed clinical data
• Strict literature search strategies
• Evaluation of equivalent devices
• Post-market clinical follow-up (PMCF) plans
• Benefit–risk analysis
• Continuous updates

Notified Bodies now perform deeper assessments and expect high-quality documentation. Manufacturers must ensure that CERs are written by trained professionals with a strong understanding of clinical research, regulatory guidelines and scientific literature.

Components of a Complete Clinical Evaluation Report

A compliant CER combines scientific literature, clinical trial data, device performance data, risk analysis and post-market information. The major sections of a CER include the following.

1. Device Description and Intended Use

This section explains what the device is, how it works and where it is used. It also describes the device classification, components, design features and intended user population.

A clear and detailed description helps Notified Bodies understand the scientific background and context of the clinical evaluation.

2. Clinical Background of the Medical Condition

The CER must include an overview of the medical condition or clinical need that the device addresses. This helps demonstrate the relevance, importance and expected benefits of using the device in clinical practice.

3. Literature Search and Appraisal

One of the most important parts of a CER is the systematic literature review. The process includes:

• Developing a clear search strategy
• Selecting scientific databases
• Applying inclusion and exclusion criteria
• Screening abstracts and full texts
• Assessing study quality
• Extracting clinical data
• Summarizing evidence

Regulators expect complete transparency in the review process. Every step must be scientifically justified and all evidence must be appraised based on relevance and quality.

4. Clinical Data from Studies and Clinical Investigations

Clinical data can come from pre-market or post-market studies. The CER must analyze data such as:

• Clinical trial results
• Pilot studies
• Observational studies
• Case series
• Real-world performance data

For high-risk devices, strong clinical evidence is mandatory. The CER must discuss outcomes, adverse events, study limitations and overall performance.

5. Evaluation of Equivalent Devices

If the manufacturer relies on clinical data from a similar or equivalent device, strict requirements must be met. Under EU MDR, equivalence must be demonstrated based on:

• Technical characteristics
• Biological characteristics
• Clinical characteristics

Many manufacturers struggle with equivalence because the requirements are now stricter. Accuprec helps identify suitable equivalent devices and prepares scientific justifications.

6. Clinical Benefit–Risk Analysis

The CER must provide a detailed comparison of clinical benefits versus potential risks. The analysis must be based on scientific data, not assumptions. Notified Bodies want to see evidence-based justifications and clear connections between risks, controls and residual risk acceptability.

7. Post-Market Surveillance and PMCF Data

The CER must include data from post-market activities such as:

• Customer complaints
• Adverse event reports
• Vigilance trends
• Published safety alerts
• Post-market clinical follow-up studies

This shows whether the device continues to perform safely after being marketed.

8. Conclusion and Clinical Evidence Summary

The report must end with a scientific conclusion that answers three critical questions:

• Is the device safe?
• Is the device performing as intended?
• Do benefits outweigh the risks?

Only after addressing these points can a device be considered clinically compliant.

How Accuprec Supports Manufacturers with CER Development

Accuprec Research Labs offers end-to-end CER preparation services. Manufacturers benefit from our structured and compliant approach that meets EU MDR requirements. Our support includes:

• Literature search strategy development
• Systematic database search
• Data screening and extraction
• Critical appraisal of studies
• Equivalence assessment
• Clinical data analysis
• Benefit–risk evaluation
• Full CER drafting and formatting
• Support during Notified Body queries
• Periodic CER updates

Accuprec combines scientific expertise with regulatory knowledge to deliver high-quality CERs accepted by global authorities.

The Importance of Accurate and Compliant CERs

Without a compliant CER, manufacturers risk:

• Delayed approvals
• Device recalls
• Regulatory non-compliance
• Rejection by Notified Bodies
• Loss of market access

As EU MDR continues to evolve, high-quality CERs are essential for maintaining CE marking and ensuring patient safety.

Conclusion

Clinical Evaluation Reports are a cornerstone of medical device regulatory compliance. They provide the scientific foundation needed to prove safety, performance and clinical benefit. With regulations becoming more demanding, manufacturers must partner with experts who understand global clinical requirements.

Accuprec Research Labs supports companies with complete CER development that meets EU MDR and MEDDEV 2.7/1 Rev. 4 standards. Backed by strong scientific methods and regulatory expertise, Accuprec helps manufacturers achieve faster approvals and maintain compliance throughout the product lifecycle.

For more information: